Identification of 4-2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-([(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT KinaseHEERDING, Dirk A; RHODES, Nelson; YAMASHITA, Dennis S et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 18, pp 5663-5679, issn 0022-2623, 17 p.Article

2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivityHONG LIN; YAMASHITA, DennisS; ZHIHONG LAI et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 2, pp 673-678, issn 0960-894X, 6 p.Article

Monoclonal antibodies generated against recombinant ATM support kinase activityALLIGOOD, Krystal J; MILLA, Marcos; RHODES, Nelson et al.Hybridoma. 2000, Vol 19, Num 4, pp 317-321, issn 0272-457XArticle

2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazolesHONG LIN; YAMASHITA, Dennis S; ZHIHONG LAI et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 2, pp 679-683, issn 0960-894X, 5 p.Article

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor ActivityRHODES, Nelson; HEERDING, Dirk A; KAHANA, Jason A et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2366-2374, issn 0008-5472, 9 p.Article

A simple method for predicting serum protein binding of compounds from IC₅₀ shift analysis for in vitro assaysRUSNAK, David W; ZHIHONG LAI; LANSING, Timothy J et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 9, pp 2309-2312, issn 0960-894X, 4 p.Article